We are live on
!
Find out more
DCM
DAFNA Capital Management Portfolio holdings
AUM
$440M
1-Year Est. Return
109.12%
This Fund
S&P 500
This Quarter
Est. Return
+9.25%
1 Year Est. Return
+109.12%
3 Year Est. Return
+239.59%
5 Year Est. Return
+227.89%
10 Year Est. Return
+3,611.91%
AUM
$398M
AUM Growth
+$20.8M
(+5.5%)
Cap. Flow
+$11.1M
Cap. Flow
% of AUM
2.8%
Top 10 Holdings %
Top 10 Hldgs %
51.36%
Holding
92
New
12
Increased
23
Reduced
18
Closed
5
Top Buys
| 1 |
CBAY
Cymabay Therapeutics
CBAY
|
+$4.8M |
| 2 |
Syndax Pharmaceuticals
SNDX
|
+$3.99M |
| 3 |
Axogen
AXGN
|
+$3.98M |
| 4 |
Adicet Bio
ACET
|
+$3.83M |
| 5 |
Biomea Fusion
BMEA
|
+$3.32M |
Top Sells
| 1 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
+$11.8M |
| 2 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$3.81M |
| 3 |
KDMN
Kadmon Holdings, Inc.
KDMN
|
+$2.74M |
| 4 |
AFMD
Affimed
AFMD
|
+$2.43M |
| 5 |
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
|
+$1.83M |
Sector Composition
| 1 | Healthcare | 94.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Stereotaxis
STXS
$161M
| $84.8M | 21.33% |
13,680,554
| – | – |
|
|
BPMC
2
DELISTED
Blueprint Medicines
BPMC
| $22.2M | 5.57% |
206,911
| – | – |
|
3
Fate Therapeutics
FATE
$349M
| $21.8M | 5.48% |
372,160
+27,800
| +8% | +$1.58M |
|
|
4
Adicet Bio
ACET
$81.1M
| $12.8M | 3.22% |
45,823
+22,305
| +95% | +$3.83M |
|
5
Xenon Pharmaceuticals
XENE
$6.55B
| $12.6M | 3.16% |
402,667
-3,868
| -1% | -$116K |
|
|
ARNA
6
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $11.1M | 2.8% |
119,615
| – | – |
|
7
IDEAYA Biosciences
IDYA
$3.54B
| $10.9M | 2.73% |
460,061
| – | – |
|
8
DexCom
DXCM
$28.1B
| $9.74M | 2.45% |
72,552
-12,000
| -14% | -$1.72M |
|
|
KRTX
9
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $9.49M | 2.39% |
72,423
-2,162
| -3% | -$279K |
|
10
Nurix Therapeutics
NRIX
$2.48B
| $8.87M | 2.23% |
306,320
| – | – |
|
|
MORF
11
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $8.6M | 2.16% |
181,467
| – | – |
|
|
BHVN
12
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $8.01M | 2.01% |
58,100
-30,000
| -34% | -$3.81M |
|
|
SAGE
13
DELISTED
Sage Therapeutics
SAGE
| $7.67M | 1.93% |
180,306
| – | – |
|
|
MRUS
14
DELISTED
Merus
MRUS
| $7.19M | 1.81% |
226,089
+94,140
| +71% | +$2.66M |
|
15
Neurocrine Biosciences
NBIX
$17.3B
| $7.13M | 1.79% |
83,655
-1,000
| -1% | -$92K |
|
|
16
Syndax Pharmaceuticals
SNDX
$2.08B
| $6.49M | 1.63% |
296,535
+215,833
| +267% | +$3.99M |
|
17
iShares Biotechnology ETF
IBB
$9.24B
| $6.24M | 1.57% |
40,900
| – | – |
|
18
Cytokinetics
CYTK
$11.2B
| $6.11M | 1.54% |
134,094
-40,906
| -23% | -$1.58M |
|
|
CBAY
19
DELISTED
Cymabay Therapeutics
CBAY
| $6.04M | 1.52% |
1,787,569
+1,263,283
| +241% | +$4.8M |
|
|
CSII
20
DELISTED
Cardiovascular Systems, Inc.
CSII
| $5.39M | 1.36% |
286,988
+93,247
| +48% | +$2.49M |
|
21
Revolution Medicines
RVMD
$39.2B
| $5.34M | 1.34% |
212,231
+2,500
| +1% | +$70.5K |
|
22
AtriCure
ATRC
$1.75B
| $5.01M | 1.26% |
72,029
| – | – |
|
23
Arcus Biosciences
RCUS
$3.52B
| $4.74M | 1.19% |
117,200
-6,500
| -5% | -$252K |
|
|
LITS
24
Lite Strategy Inc
LITS
$33.7M
| $4.71M | 1.18% |
88,242
+56,192
| +175% | +$3.13M |
|
|
ISEE
25
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $4.61M | 1.16% |
275,976
+59,625
| +28% | +$977K |
|
Similar funds
FGWP
STCG
SCP
CAAM
AWM
HCM
CPW
DWML